Technical Analysis for GBIO - Generation Bio Co.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 3.79 | 7.06% | 0.25 |
Earnings due: Jun 6
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Shooting Star Candlestick | Bearish | 0.00% | |
Lizard Bearish | Bearish Day Trade Setup | 0.00% | |
MACD Bullish Centerline Cross | Bullish | 0.00% | |
Expansion Pivot Buy Setup | Bullish Swing Setup | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Above Upper BB | Strength | 0.00% | |
Gapped Up | Strength | 0.00% | |
Crossed Above 20 DMA | Bullish | 7.06% | |
Crossed Above 50 DMA | Bullish | 7.06% |
Alert | Time |
---|---|
Gap Up Partially Closed | about 18 hours ago |
Up 2 ATRs | about 18 hours ago |
Gapped Up (Partial) | about 22 hours ago |
Rose Above Previous Day's High | about 22 hours ago |
1.5x Volume Pace | about 22 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 06/06/2024
Generation Bio Co. Description
Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases. The company’s non-viral platform incorporates a proprietary high-capacity DNA construct called closed-ended DNA, or ceDNA; a novel cell-targeted lipid nanoparticle delivery system, or ctLNP; and an established, scalable capsid-free manufacturing process. The company is designing therapies to provide targeted delivery of genetic payloads that include large and multiple genes across a broad array of tissues, and to be redosable for individualized and extended treatment throughout a patient’s life. The platform is designed to expand access to treatments for rare diseases and to address prevalent diseases through efficient, scalable manufacturing.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Emerging Technologies Rare Diseases Molecular Biology Gene Therapy Manufacturing Process Lipid Applied Genetics Gene Delivery
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.98 |
52 Week Low | 0.86 |
Average Volume | 244,916 |
200-Day Moving Average | 2.78 |
50-Day Moving Average | 3.32 |
20-Day Moving Average | 3.07 |
10-Day Moving Average | 3.23 |
Average True Range | 0.38 |
RSI (14) | 60.78 |
ADX | 21.77 |
+DI | 36.57 |
-DI | 15.46 |
Chandelier Exit (Long, 3 ATRs) | 3.20 |
Chandelier Exit (Short, 3 ATRs) | 3.84 |
Upper Bollinger Bands | 3.60 |
Lower Bollinger Band | 2.55 |
Percent B (%b) | 1.18 |
BandWidth | 34.05 |
MACD Line | 0.03 |
MACD Signal Line | -0.04 |
MACD Histogram | 0.0654 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.81 | ||||
Resistance 3 (R3) | 4.88 | 4.61 | 4.64 | ||
Resistance 2 (R2) | 4.61 | 4.35 | 4.58 | 4.58 | |
Resistance 1 (R1) | 4.20 | 4.19 | 4.41 | 4.13 | 4.53 |
Pivot Point | 3.93 | 3.93 | 4.03 | 3.90 | 3.93 |
Support 1 (S1) | 3.52 | 3.67 | 3.73 | 3.45 | 3.05 |
Support 2 (S2) | 3.25 | 3.51 | 3.22 | 3.00 | |
Support 3 (S3) | 2.84 | 3.25 | 2.94 | ||
Support 4 (S4) | 2.77 |